Open AccessA third case of vancomycin-resistant MRSA in the United States
Author(s) -
Ajijola J Johnson
Publication year - 2004
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.08.18.02455-en
Subject(s) - vancomycin , glycopeptide , staphylococcus aureus , methicillin resistant staphylococcus aureus , microbiology and biotechnology , medicine , antibiotics , biology , bacteria , genetics
The glycopeptide vancomycin is, for many, currently the drug of choice for treating infections due to methicillin-resistant Staphylococcus aureus (MRSA)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom